Iron connects oxygen transport in the human body with fundamental functions in plants. In both settings, actual availability and the underlying finding matter.
What is iron?
Iron (Fe) forms part of haemoglobin and myoglobin. Food supplies haem and non-haem iron; meat, pulses and fortified foods are possible sources. Vitamin C enhances non-haem iron absorption. [3]
On a label, compare the declared elemental iron. The weight of ferrous sulphate, ferrous fumarate or another compound is not the same quantity. A 100 mg compound does not automatically provide 100 mg iron. Check the iron amount per intended serving and how many tablets or capsules make up that serving.
Separate requirements, stores and treatment
Start with the purpose: balanced nutrition, investigation of an unusual blood result, or treatment of an established deficiency? These situations need different answers. A population reference does not replace diagnostic assessment; a medical trial dose is not an everyday target for healthy people.
Fatigue alone cannot decide the question. Careful assessment connects symptoms, food intake, possible losses and objective findings. Looking only at one number on a product or laboratory report can miss the context that makes the number meaningful.
Iron in human nutrition
With iron, low intake, depleted stores and anaemia must be distinguished. Additional intake should have an understandable purpose and a planned assessment of progress.
How much iron? What EFSA says
EFSA population reference intakes (PRIs) account for factors including menstrual losses and describe daily total dietary intake. The assessment uses 16 mg/day during pregnancy and lactation, considering adaptation of absorption and existing stores. [1]
Ferritin and haemoglobin answer different questions
WHO uses ferritin to assess iron stores. Inflammation can increase ferritin and conceal deficiency, so inflammatory status matters. One general threshold does not fit every clinical situation. [4]
Haemoglobin measures a different aspect from ferritin. The fatigue study below specifically enrolled women without anaemia but with low stores. A normal haemoglobin concentration therefore does not fully answer the question about stores. An unusual result, in turn, does not identify why it occurred.
To prepare for an appointment, collect recent laboratory reports with dates and units, note symptoms and their course, and list medicines and preparations. Depending on the situation, assessment includes blood losses, donations, food intake and other conditions. This turns an isolated measurement into a question that can be investigated.
What do studies show?
Vaucher et al. 2012 · 198 menstruating women · twelve weeks
Fatigue without anaemia: benefit in a defined group
Finding. Among women with ferritin below 50 µg/L and haemoglobin above 12 g/dL, fatigue scores fell more with 80 mg iron/day than placebo: 47.7% versus 28.8%.
Interpretation & limitations. Quality of life, depression and anxiety did not improve clearly. Participants were selected; this medical dose is not a recommendation for general tiredness.
Finding. Daily iron probably reduced iron-deficiency anaemia at term and the likelihood of low birthweight versus placebo or no iron.
Interpretation & limitations. Doses, baseline status and combinations varied. Evidence for several safety and other clinical outcomes remained uncertain. Searches extended to January 2024; decisions belong within antenatal care.
Swiss trial 2023 · 150 women with ferritin ≤30 µg/L
Daily or alternate days: equal totals over different periods
Finding. At equal cumulative iron doses, ferritin was similar; alternate-day intake caused fewer gastrointestinal symptoms on days when iron was taken.
Interpretation & limitations. The 100 mg doses were given daily for 90 days or on alternate days for 180 days. This does not show equally fast correction and is not a universal treatment schedule.
Meta-analysis 2025 · 11 randomised trials · 1,014 people
Newer synthesis: no clear winner for haemoglobin
Finding. Daily versus alternate-day intake showed no statistically clear difference in haemoglobin improvement. Overall adverse-event rates were also similar.
Interpretation & limitations. Certainty was very low for most outcomes. Differences in populations and doses prevent a universal conclusion. Searches ended in March 2025.
Heavy menstrual bleeding, pregnancy, frequent blood donations and certain gastrointestinal conditions increase deficiency risk. Iron can interact with levothyroxine and levodopa. High doses cause gastrointestinal effects; haemochromatosis increases overload risk. Keep preparations out of children’s reach. [3]
Any additional intake should have an agreed reason, amount, duration and review date. A complete inventory matters more than choosing a large serving. Medically treated deficiency and long-term self-supplementation with multiple preparations are different situations.
For example, a multinutrient product supplying 14 mg iron plus another providing 20 mg gives 34 mg extra intake. Food is not yet included. The arithmetic is straightforward; deciding on an appropriate amount requires individual context. Reaching a safety figure cannot replace that decision.
Iron in plants
Plants may have iron present but struggle to use it. Discolouration therefore does not establish that soil simply lacks a large amount of iron.
Why availability matters
University of Minnesota guidance describes soybean iron chlorosis particularly in calcareous, high-pH soil. Iron is often plentiful but poorly available. Yellow tissue with green veins can occur; high measured leaf iron does not reliably exclude the problem. [9]
The question is therefore more than how much iron the soil contains. Can this crop absorb and use it under the existing conditions? That differs from inadequate dietary intake in a person. The same element name does not make tests and interventions interchangeable across living systems.
Diagnosis before an application rate
Record crop and cultivar, the age of affected leaves, location and timing. Photographs help document changes but do not replace investigation.
Discuss the soil or substrate findings and sampling method with local agronomic advisers. Context is more informative than one isolated iron measurement.
Ask which intervention addresses the cause and how its effect will be evaluated. Product choice, site correction and crop choice are different decisions.
Retain untreated comparison areas when testing an intervention. Decide in advance whether the intended outcome is leaf colour, growth or yield.
Sources & further reading
Curated and checked on 18 October 2026. Selected EFSA assessments, WHO diagnostic guidance, controlled studies and agronomic literature; not an exhaustive systematic review. Dietary references are distinguished from medical trial doses.
Agronomic research and guidance · Accessed 18 October 2026
This information explains research and nutritional supply. It does not provide individual diagnosis, treatment or fertiliser recommendations, or establish efficacy of an OMNENT product.
Cookies & privacy
A little memory. Your choice.
We use no advertising or analytics cookies. With your permission, this browser can remember your language. Your privacy choice is stored for 180 days.